Your browser doesn't support javascript.
loading
Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis.
Kling, Kerstin; Domingo, Cristina; Bogdan, Christian; Duffy, Steven; Harder, Thomas; Howick, Jeremy; Kleijnen, Jos; McDermott, Kevin; Wichmann, Ole; Wilder-Smith, Annelies; Wolff, Robert.
Afiliación
  • Kling K; Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Domingo C; Center for International Health Protection, Robert Koch Institute, Berlin, Germany.
  • Bogdan C; Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich Alexander Universität (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Duffy S; Kleijnen Systematic Reviews Ltd, York, United Kingdom.
  • Harder T; Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Howick J; Kleijnen Systematic Reviews Ltd, York, United Kingdom.
  • Kleijnen J; Kleijnen Systematic Reviews Ltd, York, United Kingdom.
  • McDermott K; Kleijnen Systematic Reviews Ltd, York, United Kingdom.
  • Wichmann O; Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Wilder-Smith A; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
  • Wolff R; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Clin Infect Dis ; 75(12): 2266-2274, 2022 12 19.
Article en En | MEDLINE | ID: mdl-35856638
The duration of protection after a single dose of yellow fever vaccine is a matter of debate. To summarize the current knowledge, we performed a systematic literature review and meta-analysis. Studies on the duration of protection after 1 and ≥2 vaccine doses were reviewed. Data were stratified by time since vaccination. In our meta-analysis, we used random-effects models. We identified 36 studies from 20 countries, comprising more than 17 000 participants aged 6 months to 85 years. Among healthy adults and children, pooled seroprotection rates after single vaccination dose were close to 100% by 3 months and remained high in adults for 5 to 10 years. In children vaccinated before age 2 years, the seroprotection rate was 52% within 5 years after primary vaccination. For immunodeficient persons, data indicate relevant waning. The extent of waning of seroprotection after yellow fever vaccination depends on age and immune status at primary vaccination.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacuna contra la Fiebre Amarilla Tipo de estudio: Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacuna contra la Fiebre Amarilla Tipo de estudio: Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos